⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | ICICI Prudential Nifty Pharma Index Fund - Regular Plan - IDCW | ICICI Prudential Silver ETF |
|---|---|---|
| Snapshot | ||
| AMC | — | — |
| Category | Index Funds - Other | ETFs - Silver |
| NAV | ₹20.10 (17 Sep 2026) | ₹226.79 (17 Sep 2026) |
| Rating | ★★★★★ | ★★★★★ |
| Benchmark | NIFTY PHARMA - TRI | Silver |
| Fund Manager | Nishit Patel | Gaurav Chikane |
| Inception | 14 Dec 2022 | 24 Jan 2022 |
| Returns | ||
| 1Y | 16.81% | 77.00% |
| 3Y | 18.10% | 46.06% |
| 5Y | — | — |
| Since Inception | 19.88% | 30.20% |
| Risk | ||
| 14.57 | 37.91 | |
| 0.99 | -0.11 | |
| 1.01 | 1.10 | |
| -1.41 | 42.04 | |
| 2.29 | 3.22 | |
| -9.68% | -22.80% | |
| Costs | ||
| Expense Ratio | 1.19% | 0.40% |
| Exit Load | Nil | — |
| Min SIP | ₹1,000 | — |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
ICICI Prudent…100%
ICICI Prudent…100%
0.0%Only 0.0% of holdings by weight are common between ICICI Prudential Nifty Pharma Index Fund - Regular Plan - IDCW and ICICI Prudential Silver ETF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Category context: Index / ETF vs Index / ETF. Open the full Screener →